Advertisement

Topics

FDA grants fast track designation to haemoglobin spray for diabetic foot ulcers

04:00 EST 10 Nov 2017 | EPM Magazine

The US Food and Drug Administration (FDA) has granted fast track designation to Infirst Healthcare’s haemoglobin spray, Granulox, for the treatment of diabetic foot ulcers (DFUs).

Original Article: FDA grants fast track designation to haemoglobin spray for diabetic foot ulcers

NEXT ARTICLE

More From BioPortfolio on "FDA grants fast track designation to haemoglobin spray for diabetic foot ulcers"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...